Drug profile · INN
ibuprofen lysine
NEOPROFEN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ibuprofen lysine (NEOPROFEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN ibuprofen lysine
Brand NEOPROFEN
Route INTRAVENOUS
Formulation INJECTABLE
Frequently asked questions
What is ibuprofen lysine?
ibuprofen lysine (NEOPROFEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for ibuprofen lysine?
NEOPROFEN is a marketed brand name for ibuprofen lysine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ibuprofen lysine?
ibuprofen lysine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.